Sandor Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 10.90 Cr
as on 08-07-2024
- Paid Up Capital ₹ 10.73 Cr
as on 08-07-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 74.31 Cr
as on 08-07-2024
- Satisfied Charges ₹ 19.51 Cr
as on 08-07-2024
- Revenue -70.81%
(FY 2021)
- Profit -6.45%
(FY 2021)
- Ebitda 61.47%
(FY 2021)
- Net Worth -20.67%
(FY 2021)
- Total Assets 11.75%
(FY 2021)
About Sandor Life Sciences
The Corporate was formerly known as Sandor Proteomics Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 10.90 Cr and a paid-up capital of Rs 10.73 Cr.
The company currently has active open charges totaling ₹74.31 Cr. The company has closed loans amounting to ₹19.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tirunelveli Devarajan, Gunjan Sindhi, Rajeev Sindhi, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110TG2004PTC043672
- Company No.
043672
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jul 2004
- Date of AGM
03 Jul 2023
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sandor Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Sindhi  | Managing Director | 16-Jul-2004 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tirunelveli Devarajan | Director | 08-Jan-2016 | Current |
| Gunjan Sindhi | Director | 16-Dec-2015 | Current |
| Subramanian Vasudevan | Director | 11-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Sandor Life Sciences.
Sandor Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 70.81% decrease. The company also saw a slight decrease in profitability, with a 6.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sandor Life Sciences?
In 2020, Sandor Life Sciences had a promoter holding of 80.52% and a public holding of 19.48%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Malladi Drugs And Pharmaceuticals LimitedActive 44 years 4 monthsTirunelveli Devarajan and Subramanian Vasudevan are mutual person
Alniche Lifesciences Private LimitedActive 12 years 1 monthTirunelveli Devarajan is a mutual person
Ankura Medical & Research Centre Private LimitedActive 13 years 7 daysTirunelveli Devarajan is a mutual person
Phasorz Technologies Private LimitedActive 11 years 4 monthsTirunelveli Devarajan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 Jan 2023 | ₹3.15 Cr | Open |
Others Creation Date: 20 Aug 2021 | ₹1.86 Cr | Open |
Tata Capital Financial Services Limited Creation Date: 30 Oct 2019 | ₹1.50 Cr | Open |
How Many Employees Work at Sandor Life Sciences?
Sandor Life Sciences has a workforce of 1 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sandor Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandor Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
